Mike Snyder, Personalized Medicine, Open Access, SBGN, and the 1,000 Genomes Project | GenomeWeb

In Genome Technology's cover story five years ago, we looked into the tech transfer process, with our cover image showing off Mike Snyder, who worked with the Yale tech transfer group to start his company Protometrix. The startup was acquired by Invitrogen not long after the story ran. Since then, Snyder has spun out another company — this one called Affomix, which is working on large-scale antibody arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.